Page last updated: 2024-09-04

tipifarnib and Hypoxia

tipifarnib has been researched along with Hypoxia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdul-Salam, VB; Ahmetaj-Shala, B; Aldabbous, L; Dubois, OD; Duluc, L; Iannone, L; Mahomed, AS; Mitchell, J; Oliver, E; Storck, EM; Tate, EW; Wilkins, MR; Wojciak-Stothard, B; Zhao, L1
Merkus, D; Schermuly, RT1

Other Studies

2 other study(ies) available for tipifarnib and Hypoxia

ArticleYear
Tipifarnib prevents development of hypoxia-induced pulmonary hypertension.
    Cardiovascular research, 2017, 03-01, Volume: 113, Issue:3

    Topics: Animals; Antihypertensive Agents; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Hypertension, Pulmonary; Hypoxia; Male; Mice, Inbred C57BL; Phenotype; Protein Prenylation; Proteomics; Pulmonary Artery; Quinolones; rhoB GTP-Binding Protein; Time Factors; Transfection; Vasoconstriction; Vasodilation

2017
Farnesylation of RhoB: the cancer hypothesis of pulmonary hypertension revisited.
    Cardiovascular research, 2017, 03-01, Volume: 113, Issue:3

    Topics: Humans; Hypertension, Pulmonary; Hypoxia; Neoplasms; Prenylation; Quinolones; rhoB GTP-Binding Protein

2017